Literature DB >> 24945954

Fluorescence anisotropy-based measurement of Pseudomonas aeruginosa penicillin-binding protein 2 transpeptidase inhibitor acylation rate constants.

Adam B Shapiro1, Ning Gao2, Rong-Fang Gu3, Jason Thresher3.   

Abstract

High-molecular-weight penicillin-binding proteins (PBPs) are essential integral membrane proteins of the bacterial cytoplasmic membrane responsible for biosynthesis of peptidoglycan. They are the targets of antibacterial β-lactam drugs, including penicillins, cephalosporins, and carbapenems. β-Lactams covalently acylate the active sites of the PBP transpeptidase domains. Because β-lactams are time-dependent inhibitors, quantitative assessment of the inhibitory activity of these compounds ideally involves measurement of their second-order acylation rate constants. We previously described a fluorescence anisotropy-based assay to measure these rate constants for soluble constructs of PBP3 (Anal. Biochem. 439 (2013) 37-43). Here we report the expression and purification of a soluble construct of Pseudomonas aeruginosa PBP2 as a fusion protein with NusA. This soluble PBP2 was used to measure second-order acylation rate constants with the fluorescence anisotropy assay. Measurements were obtained for mecillinam, which reacts specifically with PBP2, and for several carbapenems. The assay also revealed that PBP2 slowly hydrolyzed mecillinam and was used to measure the rate constant for this deacylation reaction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BOCILLIN; Fluorescence anisotropy; Fluorescence polarization; PBP2; Penicillin-binding protein; Transpeptidase

Mesh:

Substances:

Year:  2014        PMID: 24945954     DOI: 10.1016/j.ab.2014.06.004

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.

Authors:  William F Penwell; Adam B Shapiro; Robert A Giacobbe; Rong-Fang Gu; Ning Gao; Jason Thresher; Robert E McLaughlin; Michael D Huband; Boudewijn L M DeJonge; David E Ehmann; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

2.  ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

Authors:  Thomas F Durand-Réville; Satenig Guler; Janelle Comita-Prevoir; Brendan Chen; Neil Bifulco; Hoan Huynh; Sushmita Lahiri; Adam B Shapiro; Sarah M McLeod; Nicole M Carter; Samir H Moussa; Camilo Velez-Vega; Nelson B Olivier; Robert McLaughlin; Ning Gao; Jason Thresher; Tiffany Palmer; Beth Andrews; Robert A Giacobbe; Joseph V Newman; David E Ehmann; Boudewijn de Jonge; John O'Donnell; John P Mueller; Rubén A Tommasi; Alita A Miller
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

3.  Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.

Authors:  Sarah M McLeod; Adam B Shapiro; Samir H Moussa; Michele Johnstone; Robert E McLaughlin; Boudewijn L M de Jonge; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 4.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

5.  Rational design of a new antibiotic class for drug-resistant infections.

Authors:  Thomas F Durand-Reville; Alita A Miller; John P O'Donnell; Xiaoyun Wu; Mark A Sylvester; Satenig Guler; Ramkumar Iyer; Adam B Shapiro; Nicole M Carter; Camilo Velez-Vega; Samir H Moussa; Sarah M McLeod; April Chen; Angela M Tanudra; Jing Zhang; Janelle Comita-Prevoir; Jan A Romero; Hoan Huynh; Andrew D Ferguson; Peter S Horanyi; Stephen J Mayclin; Henry S Heine; George L Drusano; Jason E Cummings; Richard A Slayden; Ruben A Tommasi
Journal:  Nature       Date:  2021-09-15       Impact factor: 49.962

6.  Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3.

Authors:  Arancha López-Pérez; Stefan Freischem; Immanuel Grimm; Oliver Weiergräber; Andrew J Dingley; María Pascual López-Alberca; Herbert Waldmann; Waldemar Vollmer; Kamal Kumar; Cuong Vuong
Journal:  Antibiotics (Basel)       Date:  2021-05-04

Review 7.  Promiscuous Enzyme Activity as a Driver of Allo and Iso Convergent Evolution, Lessons from the β-Lactamases.

Authors:  Vivek Keshri; Eric Chabrière; Lucile Pinault; Philippe Colson; Seydina M Diene; Jean-Marc Rolain; Didier Raoult; Pierre Pontarotti
Journal:  Int J Mol Sci       Date:  2020-08-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.